Indian tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 3.2% during the forecast period. As per World Health Organization (WHO), A total of 1.5 million people have mortality from TB in 2018 (including 251 000 people with HIV). Across the globe, TB is one of the top 10 causes of mortality and the leading cause from a single infectious agent (above HIV/AIDS). Additionally, in 2018, an estimated 10 million people fell ill with tuberculosis (TB) across the globe. Various government initiatives in the country are responsible for the significant growth of the market. For instance, Revised National Tuberculosis Control Program (RNTCP) is the major state-run tuberculosis (TB) control initiative of the Government of India. As per the National Strategic Plan 2012–17, this aimed to achieve a “TB free India”. The program’s major goal is to achieve Universal Access to TB control services. Moreover, it provides various free of cost, quality tuberculosis diagnosis and treatment services across the country with the enables of various government health system.
To Request a Sample of our Report on Indian Tuberculosis Diagnosis and Treatment Market: https://www.omrglobal.com/request-sample/indian-tuberculosis-diagnosis-treatment-market
Indian tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.
(Get 15% Discount on Buying this Report)
A full Report of Indian Tuberculosis Diagnosis and Treatment Market is Available @ https://www.omrglobal.com/industry-reports/indian-tuberculosis-diagnosis-treatment-market
Indian Tuberculosis Diagnosis and Treatment Market Segmentation
By Drugs Type
- First Line Drugs
- Second Line Drugs
By Diagnosis
- Laboratory Testing
- Nucleic Acid Amplification Test
- Mantoux Test
- Radiography
- Drug Susceptibility Testing
Company Profiles
- Abbott Laboratories
- Becton, Dickinson and Co.
- Biochemical and Synthetic Products Pvt Ltd.
- Eiken Chemical Co., Ltd.
- F. Hoffmann-La Roche Ltd.
- Labatec Pharma SA
- Lupin Pharmaceuticals, Inc.
- Thermo Fisher Scientific
- GlaxoSmithKline PLC
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
